You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RGNX Sale Disclosure
Pakola Steve · SEC Form 4 · Filed Jul 1, 2026
Sale
Calculated transaction value
$216.47K
Pakola Steve Chief Medical Officer
RGNX
REGENXBIO Inc
RGNX
Transaction date
Jun 29, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed 2 days later
RGNX daily price context
Close on/before transaction
$11.83
Jun 29, 2026
First close after public filing
$13.28
Jul 2, 2026
30-day return after filing
-27.03%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 19,608 shares @ $11.04
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001700659-26-000012
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$977.41K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regenxbio Inc. RGNX | Exercise | Jul 1, 2026 | $0 |
| Regenxbio Inc. RGNX | Exercise | Jul 1, 2026 | $288.66K |
| Regenxbio Inc. RGNX | Sale | Jul 1, 2026 | $472.28K |
| Regenxbio Inc. RGNX Current | Sale | Jun 29, 2026 | $216.47K |